ABsTrACT
Objectives Mast cells (MCs) are involved in the pathogenesis of rheumatoid arthritis (rA). However, their contribution remains controversial. to establish their role in rA, we analysed their presence in the synovium of treatment-naïve patients with early rA and their association and functional relationship with histological features of synovitis. Methods Synovial tissue was obtained by ultrasoundguided biopsy from treatment-naïve patients with early rA (n=99). Immune cells (Cd3/Cd20/Cd138/Cd68) and their relationship with Cd117 + MCs in synovial tissue were analysed by immunohistochemistry (IHC) and immunofluorescence (IF) . the functional involvement of MCs in ectopic lymphoid structures (ELS) was investigated in vitro, by coculturing MCs with naïve B cells and anticitrullinated protein antibodies (ACpA)-producing B cell clones, and in vivo in interleukin-27 receptor alpha (IL27ra)-deficient and control mice during antigen-induced arthritis (AIA). results High synovial MC counts are associated with local and systemic inflammation, autoantibody positivity and high disease activity. IHC/IF showed that MCs reside at the outer border of lymphoid aggregates. Furthermore, human MCs promote the activation and differentiation of naïve B cells and induce the production of ACpA, mainly via contact-dependent interactions. In AIA, synovial MC numbers increase in IL27ra deficient mice, in association with ELS and worse disease activity. Conclusions Synovial MCs identify early rA patients with a severe clinical form of synovitis characterised by the presence of ELS.
InTrOduCTIOn
Mast cells (MCs) are tissue-resident cells of the innate immunity, involved in several physiological and pathological processes, including infections, cancer and chronic inflammatory diseases. 1 2 They are present in the synovial membrane (SM) and have been implicated in contributing to the inflammatory response in several rheumatic diseases, 3 including rheumatoid arthritis (RA). 4 Notably, MCs are present in healthy synovia, 5 but their number significantly increases accompanying the cellular hyperplasia characteristic of RA synovitis. [6] [7] [8] Many MC mediators have direct proarthritogenic effects, [9] [10] [11] [12] and MCs can be activated by several stimuli present in the synovium/ synovial fluid, such as anticitrullinated protein antibodies (ACPA) IgG immune complexes. 13 However, recent evidence suggests that MC contribution to autoimmune diseases can be complex and multifaceted. 14 In the context of RA, for example, human MCs have been shown to exert immunomodulatory functions in vitro. 15 In vivo, initial findings were contrasting, [16] [17] [18] most likely because of the use of animal models in which MC depletion was accompanied by anomalies of other immune cells. 19 In recent years, thanks to the development of new specific models of MC depletion, 20 their contribution has been confirmed to be essential in collagen-induced arthritis (CIA) but redundant in serum-transfer arthritis. 21 Additionally, their depletion in the preclinical phases of CIA, rather than in the established phases, was shown to influence the disease outcome. 22 These results in vivo suggest that the contribution of MCs to RA may be different at various disease stages, that is, essential during the early phases (assessed by CIA) but somehow dispensable during the late effector phases (serum transfer). However, while these models are self-resolving, in RA, there is chronic inflammation with a perpetuation of the aberrant autoimmune response; therefore, the results cannot be easily translated to the clinical setting. Overall, despite the substantial amount of data, the role of MCs in RA remains to be clarified. 4 As RA is well-recognised as a heterogeneous syndrome in terms of genetic predisposition, pathogenesis, clinical 23 24 and histological 25 features, it could be hypothesised that MC presence and functions in the synovium may be different in various disease subsets. To explore this hypothesis, we systematically analysed the presence of MCs in the synovia of a large cohort of disease-modifying antirheumatic drugs (DMARD)-naïve patients with early RA. Furthermore, we assessed their interactions with immune cells at synovial level and analysed in vitro the crosstalk of MCs with B cells. Finally, we evaluated the relationship between MC synovial infiltration and ectopic lymphoid structures (ELS) in an experimental model of synovial ectopic lymphoid neogenesis. 
Basic and translational research

Histological analyses of synovial samples
Synovial sections underwent standard H&E staining and semiquantitative (SQ) assessment of synovitis according to a previously validated score (Krenn) . 28 Sequentially cut sections underwent immunohistochemical (IHC) staining and SQ assessment (0-4) for immune cells, as previously reported 29 and automated image analysis and counting for CD117-positive MCs. Patients were classified into high, medium and low MC groups (>66th, 33rd-66th, <33rd percentiles, respectively) (online supplementary methods).
Peripheral blood-derived MCs
CD34
+ haematopoietic stem cells (StemPro CD34+ kit, ThermoFisher) were differentiated into MCs as previously described 30 (online supplementary methods and online supplementary figure 1 for MC purity). 
naïve B cell isolation and coculture with MCs
Flow cytometry
Flow cytometry staining was performed as previously described 32 (online supplementary methods).
Measurement of immunoglobulins
Please check online supplementary methods.
Antigen-induced arthritis (AIA) in wild-type and interleukin-27 receptor (IL27ra) knock out
AIA was induced in adult (8-12 weeks) IL27ra−/− mice and age-matched/sex-matched WT as previously described. 33 Five-micrometre sections of synovia from animals culled at different intervals (days 3, 10 and 35) were processed and analysed as described. 33 To visualise MCs, sequentially cut sections were stained with acidic Toluidine Blue (Sigma) 0.1% solution (pH 2.0~2.5) (online supplementary methods).
statistical analyses
Measures of central tendency and dispersions and statistical analyses are indicated in each figure legend and in online supplementary methods. P values of <0.05 were considered statistically significant.
resuLTs
MCs strongly associate with defined histological features of synovitis and markers of disease activity in patients with early rA
To evaluate the association of MCs with different clinical and histological phenotypes of RA in an unbiased setting, we studied their presence in the SMs of patients with early RA, naïve to treatment with DMARDs. Table 1 summarises the demographic features of the patient cohort, which are as expected for a population with early untreated RA, that is, active disease, with a mean disease activity score (DAS)-28 of 5.62, high inflammatory markers, with a mean erythrocyte sedimentation rate (ESR) of 38 mm/hour and approximately 70% autoantibody positive -rheumatoid factor (RF) or ACPA.
First, we assessed the correlation of MC density with markers of both local (synovial) and systemic inflammation and disease activity. Figure 1A demonstrates that MC counts significantly correlate with inflammatory markers (ESR and C reactive protein (CRP)), disease activity (DAS-28) and synovial inflammation (Krenn Score). Interestingly, MCs correlated with other immune cells in SMs, with particularly high correlation indexes for B cell and T cells (Spearman r 0.617 and 0.519, respectively, p<0.001). Since MC infiltration in synovial specimens was heterogenous, we stratified patients according to the number of MCs into three groups (low, medium and high MC counts), as shown in figure 1B . Consistent with the strong correlation shown in figure 1A , high T cell and B cell scores were predominant in patients with high MC counts (figure 1C,D). As these data indicate that MCs correlate with synovial inflammation and the degree of lymphocyte infiltration, we evaluated the presence of MCs in three classified forms of synovitis (pathotypes): lymphoid, myeloid and pauci-immune/fibroid. 25 Interestingly, more than 80% of patients with high MC synovial counts displayed a lymphoid-rich pathotype, characterised by synovial T cell and B cell aggregates; vice versa, as expected, the number of MCs was significantly higher in patients with a lymphoid pathotype ( figure 1E,F) . These data indicate that MCs are strongly associated with lymphoid aggregates in the synovia of patients with early RA. Next, we investigated the heterogeneity of synovial MCs. Two types of MCs have been described in humans, expressing tryptase alone (MC_T) or tryptase and chymase (MC_TC), with the following distribution in synovium: predominance of MC_TC in normal synovium, 5 expansion of both in RA, 7 with relative increase of MC_T described in early 8 and late RA. 34 By performing double immunofluorescence in a subgroup of patients from our early RA cohort (n=15), we found both types of MCs expressed in the synovia, with significantly higher levels of MC_TC (online supplementary figure  S2A ) and an average ratio MC_T:MC_TC of 1:3. When patients were stratified according to pathotypes, we observed a significant increase of both types of MCs in the lymphoid pathotype (online supplementary figure S2B), with the ratio MC_T:MC_TC shifting from 1:6 (fibroid) to 1:2 (lymphoid). Additionally, MC_T, and not MC_TC, showed a significant correlation with synovial inflammation (online supplementary figure S2C and D) . Online supplementary figure S2E shows a representative image with an abundance of MC_T in a patient with lymphoid pathotype. These data suggest an enrichment of tryptase expressing synovial MCs (MC_T) in the lymphoid pathotype in association with the degree of inflammation. Finally, we assessed the clinical phenotype of patients stratified according to MCs. As shown in table 2, patients with medium and high MC counts have significantly raised ESR and disease activity (DAS-28) compared with low MC counts, and patients with high MCs have a significantly higher prevalence of autoantibody positivity (ACPA and RF) compared with low and medium MCs. To exclude that the association of MCs with disease severity was exclusively driven by their association with lymphoid cells, we performed additional analyses excluding lymphoid patients and found that MCs were significantly correlated with ESR (Spearman r=0.272, p=0.007), CRP (r=0.217, p=0.033) and DAS-28 (r=0.308, p=0.002). Overall, this suggests that the stratification of patients according to synovial MCs identifies patients with a severe clinical phenotype.
Basic and translational research
MCs interact with T and B cells in follicular structures in rA synovium and tonsil tissue
Having established the presence of MCs in the synovial biopsies from early RA patients with lymphoid-rich sysnovitis, we next investigated the distribution of MCs in the synovia of patients with a lymphoid pathotype. A representative example of the synovial histology of these patients is shown in figure 2A . IHC staining of sequential sections confirmed the presence of CD117+ synovial MCs (figure 2B). By immunofluorescence, we identified MCs bordering lymphoid aggregates, in close contact with B and T cells (figure 2C). A similar distribution was observed in the highly organised secondary lymphoid organs (SLOs) from tonsil tissue, used as controls ( figure 2D) .
Thus, MCs reside on the outer boundary of B and T cell aggregates and are a histological feature of both synovial ELS and SLOs.
MCs enhance B cell survival, proliferation and differentiation and production of class-switched Ig and ACPA
As MCs were found in the proximity of B and T cell aggregates in SMs, and because the activation of B cells towards the production of autoantibodies locally contributes to the pathogenic process in RA, 29 we hypothesised that human MCs could influence the activation of B cells. To test this hypothesis, we cultured naïve B cells isolated from tonsils with in vitro differentiated human MCs, using the TLR9 ligand CpG to boost B cell activation. 35 MCs enhanced the survival of naïve B cells ( figure 3A) with a significant increase in IgG secretion but only minor changes in IgM production (figure 3B). Since CpG per se lacks the ability to induce a full differentiation of naïve B cells, 36 37 the production of IgG on coculture of MCs with naïve B cells suggest that MCs can provide additional signals allowing B cell differentiation and the isotype switch towards IgG ( figure 3B ). Interestingly, cell contact was not necessary to induce the MC-mediated effect on B cell survival, indicating that soluble factors were sufficient ( figure 3C ). Additionally, MCs were enhancing the proliferation of CFSE-labelled naïve B cells, and this effect was again not dependent on cell contact ( figure 3D ). On the contrary, the production of IgG was significantly dependent on cell contact, suggesting that membrane-bound factors were responsible (figure 3E). Similarly, MCs were able to enhance the production of RA-specific autoantibodies (ACPA) by B cells (figure 3F), an effect again dependent on cell contact. Collectively, these data indicate that MCs can induce the survival, proliferation and differentiation of naïve B cells towards IgG-secreting B cells via indirect and direct cell-cell contact.
Next, we investigated the mechanisms by which human MCs promote IgG production by B cells and demonstrated that this is CD40L dependent (figure 3G), confirming previous reports indicating that murine MCs mediate B cell activation through this cell surface costimulatory molecule. 38 39 To further confirm the ability of MCs to induce the differentiation of naïve B cells towards antibody-producing memory B cells, we analysed B cells by flow cytometry after 7 days of coculture with MCs. Figure 3H shows that coculture of naïve B cell with MCs increased the number of antibody-producing memory B cells (CD27+/CD38+). Interestingly, this effect could be inhibited by treatment with anti-CD40L in a dose-dependent manner, further confirming the ability of MCs to induce of B cell differentiation via CD40L-CD40 interaction (figure 3H).
As cell contact was crucial for the MC-induced differentiation of B cells, we performed phalloidin staining on MCs and B cells after 24 hours of coculture, which showed actin reorganisation in the region of contact between MCs and B cells ( figure 3I ). This suggests an active cellular interaction between MCs and B cells.
synovial MC infiltration occurs early and is associated with eLs and disease severity in AIA in IL27ra-deficient mice
Having demonstrated that human MCs enhance B cell activation and differentiation in vitro and are associated with synovial ELS in patients with early RA, we wished to investigate in vivo the relevance of the interaction between MCs and B cells within ELS in the pathogenesis of arthritis. To this end, we examined MCs synovial infiltration in AIA, a model in which acute inflammatory arthritis is induced by intra-articular injection of methylated bovine serum albumin following systemic immunisation with the same antigen. We used IL27ra-deficient mice, which develop exacerbated synovitis comprising ELS. Figure 4A ,B shows that MCs were present already in the early phases of AIA (3 days after intra-articular injection), with their numbers further increasing at day 10 (d10) and day 35 (d35) postarthritis induction. Importantly, in IL27ra-deficient mice, synovial MC infiltration was significantly higher compared with wild-type littermates at d10 and d35 ( figure 4C,D) . Moreover, at the peak of inflammation (d10) synovial MCs showed a positive correlation with arthritis index, synovial infiltrate and the presence of erosions ( figure 4E ). Finally, in IL27ra-deficient animals at d10, there was a trend towards a correlation between MCs and the area of lymphoid aggregates (figure 4F), and MCs were found at the borders of lymphoid aggregates (figure 4G), Overall, these observations confirm the association of MCs with ectopic lymphoid neogenesis and disease severity, during arthritis induction in vivo.
dIsCussIOn
In this manuscript, we present the first systematic analysis of MCs in the SM of patients with early RA obtained by ultrasound-guided synovial biopsy prior to therapeutic intervention. Our data demonstrate that synovial MCs are strongly Basic and translational research associated with specific pathobiological and clinical phenotypes potentially linked to their ability to induce the activation/differentiation of B cells and the production of ACPA autoantibodies.
Although MCs have long known to be part of the inflammatory infiltrate in RA, their presence in the SM has only been analysed in a few studies, which described increased MC numbers and mediators in the SM and synovial fluid of patients with RA, possibly in correlation with disease activity. [6] [7] [8] More recently, in a study describing the immunopathological characteristics of ultrasound-defined synovitis in patients with RA in remission, the presence of synovial MCs and B cells at baseline was associated with disease reactivation at follow-up. 40 At the same time, studies in vitro and in vivo have yielded contradictory results, so that their exact contribution is still unclear. 4 To obtain further insight into the relevance of MCs in RA, we analysed the SM of a large cohort of patients with early (<12 months) RA (n=99), unbiased by treatment and disease duration.
Our data demonstrate high synovial MC counts in patients with a severe clinical phenotype at baseline. Furthermore, MCs correlate with synovial inflammation and, in particular, with ELS, which are found in approximately 40% of patients with RA and have been associated with disease severity, T cell priming and autoantibody production, including the local ongoing production of class-switched autoantibodies, such as ACPA. 29 41 Interestingly, we found a higher prevalence of tryptase-expressing MCs (MC_T) in the synovia of patients with ELS. Although the concept of MC heterogeneity is still ill-defined, 42 the abundance of MC_T in association with the lymphoid pathotype would be in line with the proinflammatory role of this subpopulation described in asthma. 43 The strong association of MCs with ELS led us to hypothesise that MCs could modulate the local adaptive immune response. The ability of human MCs to influence T cells interaction has already been shown. 44 45 Murine MCs have been shown to activate B cells and promote their differentiation toward effector cells. 38 46 Interestingly, murine MCs were also shown to control, via CD40/ CD40L interaction, the expansion and differentiation of interleukin-10 competent B cells, which is in line with their immunomodulatory functions. 39 The interaction of human MCs and B cells has been poorly studied: in the context of allergic responses, MCs have been shown to express CD40L and induce IgE production by B cells, 47 48 while in the context of cancer, they have been shown to activate lymphoplasmacytic cells via CD40L. 49 Nonetheless, the interaction between human MCs and B cells has never been studied in the context of autoimmune diseases characterised by local B cell responses.
Here, we show that MCs are at the border of B and T cell aggregates in the synovia of patients with RA, similarly to the distribution observed in SLOs. Furthermore, we show that human MCs support the survival, activation, proliferation and differentiation of naive B cells into IgG-producing B cells, in line with recent results in mice. 46 This effect is dependent on cell contact and, specifically, on CD40L-CD40 interaction. Importantly, we demonstrate that MCs induce ACPA production by B cells, also in a contact-dependent manner, although the relevance of CD40L expression by MCs in the induction of ACPA remains to be confirmed. Furthermore, we provide the first evidence of an active interaction between human MCs and B cells, as previously shown for MC-T cells 50 and MC-Dendritic Cells. 51 In vivo, we used AIA to assess the time course and magnitude of synovial MC infiltration, and IL27ra-deficient mice as a model of exacerbated synovitis accompanied by ELS formation, 33 thus resembling RA patients with a lymphoid pathotype. In both wild-type and IL27ra deficient animals, we observed an early synovial MC infiltration, before the formation of ELS, further increasing at later stages. Whether the early synovial infiltration of MCs means that they are essential to lymphoid neogenesis remains to be established. In fact, in addition to the direct modulation of lymphocyte activation, MCs are also known to produce several mediators, 52 including angiogenic and lymphangiogenic factors, 53 54 that could support the organisation of ELS. 55 Interestingly, MC numbers were significantly higher in IL27ra-deficient animals, in association with synovial ELS and a worse disease outcome. As IL27ra deficiency has been shown to enhance the activation of MCs in the context of Th2 responses, 56 57 it will be of interest to further assess the specific role of IL27-mediated MC inhibition in autoimmune diseases.
In conclusion, our study points to the relevance of MCs in RA and their role as novel markers of synovial inflammation. In fact, their presence contributes to the definition of an MC-rich highly inflamed synovial pathotype and helps identifying patients with a severe clinical phenotype. 
